References
- Marinone G, Roncoli B, Marinone MG, Jr. Pure white cell aplasia. Semin Hematol 1991; 28: 298–302
- Zacharski IR, Elveback LR, Linman JW. Leukocyte counts in healthy adults. Am J Clin Pathol 1971; 56: 148–50
- Rouveix B, Lassued K, Vittecoq D, Regnier B. Neutropenia due to β-lactamine antibiotics. Br Med J 1983; 287: 1832–5
- McCluskey WP, Esterhai JL, Brighton CT, Heppenstall B. Neutropenia complicating parenteral antibiotic treatment of infected non-union of the tibia. Arch Surg 1989; 124: 1309–12
- Buckley MM, Brogden RN, Barradell LB. Imipemem/cilastatin. A reappraisal of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy. Drugs 1992; 44: 408–44
- Calandra GB, Brown KR, Grad LC, Ahonkai VI, Wang CW, Aziz MA. Review of adverse experiences and tolerability in the first 2156 patients treated with imipenem/cilastatin. Am J Med 1985; 78(Suppl 6A)73–8
- Farinas MC, de Vega T, Garmendia J, Gonzalez-Macias J. Severe neutropenia in a patient treated with imipenem/cilastatin. Eur J Clin Microbiol Infect Dis 1993; 12: 303–4
- Young GAR, Vincent PC. Drug-induced agranulocytosis. Clin Hematol 1980; 9: 483–504
- Levitt LJ. Chlorpropamide-induced pure white cell aplasia. Blood 1987; 69: 394–400
- Barret AJ, Weller B, Rozengurt N, Longhurst P, Humble JG. Amidopyrin agranulocytosis: drug inhibition of granulocyte colonies in the presence of patient's serum. Br Med J 1976; 2: 850–1
- Weitzman SA, Stossel TP, Desmond M. Drug-induced immunological neutropenia. Lancet 1978; 1: 1068–71
- Klastersky JA. Use of imipenem as empirical treatment of febrile neutropenia. Int J Antimicrob Agents 2003; 21: 393–402